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The aim of this study is to examine the therapeutic potential of deep sea water (DSW) on osteoporosis. Previously, we have
established the ovariectomized senescence-accelerated mice (OVX-SAMP8) and demonstrated strong recovery of osteoporosis
by stem cell and platelet-rich plasma (PRP). Deep sea water at hardness (HD) 1000 showed significant increase in proliferation of
osteoblastic cell (MC3T3) by MTT assay. For in vivo animal study, bone mineral density (BMD) was strongly enhanced followed
by the significantly increased trabecular numbers through micro-CT examination after a 4-month deep sea water treatment, and
biochemistry analysis showed that serum alkaline phosphatase (ALP) activity was decreased. For stage-specific osteogenesis, bone
marrow-derived stromal cells (BMSCs) were harvested and examined. Deep sea water-treated BMSCs showed stronger osteogenic
differentiation such as BMP2, RUNX2, OPN, and OCN, and enhanced colony forming abilities, compared to the control group.
Interestingly, most untreated OVX-SAMP8 mice died around 10 months; however, approximately 57% of DSW-treated groups
lived up to 16.6 months, a life expectancy similar to the previously reported life expectancy for SAMR1 24 months. The results
demonstratedtheregenerativepotentialsofdeepseawateronosteogenesis,showingthatdeepseawatercouldpotentiallybeapplied
in osteoporosis therapy as a complementary and alternative medicine (CAM).
1. Introduction
Osteoporosis, a common disease caused by imbalanced bone
remodeling, is a global public health problem. Patients with
osteoporosis are often accompanied with pain, disability, and
declineinthequalityoflife,riseinmortality,anddepletionof
localhealthcarebudget[1–4].Themajortypeofosteoporosis
occurred in postmenopausal women with an age range of
50–70 [5]. Bone density index rapidly decreased after the
menopause, due to sex hormone imbalance and the lack of
estrogen. The imbalance of homeostasis between osteoclasts
and osteoblasts also leads to increased boneresorption[6, 7].
In addition, senile osteoporosis with increased age and the
reduction of growth hormone (GH) which stimulates renal-
synthesized 1 alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3)
is also another cause of osteoporosis [8, 9]. Age-related bone
loss causes bone trabecular thinning as well as the loss of
cortical layer of bone tissue, and the cortex becomes porous
which will increase the femoral neck fracture rate [10]. For
osteoporosis, supplemental dietary calcium and vitamin D
may reduce the risk of fractures in postmenopausal women
[11]. Drugs, lifestyle changes, home safety, and hip protection2 Evidence-Based Complementary and Alternative Medicine
are viable approaches for the prevention of osteoporosis.
AccordingtotheWorldHealthOrganizationCriteria(WHO)
statistics, the penetration rate of osteoporosis in women over
the age of 65 is up to 35%; hence, the advanced treatment for
osteoporosis has become emergent.
Deepseawater(DSW)generallyreferstoseawaterfroma
depth of more than 200 meters (m). It could be characterized
by its purity, abundant nutrients, and minerals. Currently,
DSWhasbeenappliedinthegroundoffood,agriculture,cos-
metic, and medical field due to its high contents of unique
minerals including sodium (Na), magnesium (Mg), calcium
(Ca), potassium (K), zinc (Zn), and vanadium (V) [12].
DSW has been reported to stimulate both osteoblastogenesis
and osteoclastogenesis in bone turnover [13]. NaCl from
DSW also improves the biochemical properties of bone.
DSWcombinedwithsolublesiliconasnaturalmaterialcould
promote cell proliferation of osteoblast and enhance the
osteogenesis-related gene expression in animal studies [13].
The DSW utilized in this study is drawn from the Pacific
Ocean at a depth of 662m and a distance of 5 kilometers
(km) off the coast of Hualien County, Taiwan [14, 15], which
contains abundant amounts of trace elements, including high
concentrations of four essential minerals: Mg (96200mg/L),
K (10800mg/L), Na (9010mg/L), and Ca (39mg/L).
Our previous study has demonstrated that transplanta-
tion of platelet-rich plasma- (PRP-) treated NIH3T3-G cells
into OVX-SAMP8 mice significantly reversed osteoporosis.
We also showed that PRP could not only increase bone
r e g e n e r a t i o nb u ta l s or e d u c eb o n em a r r o wa d i p o s i t yi nt h e
osteoporotic mice [16–18]. In this study, we investigated the
possibility of the treatment of osteoporosis by DSW. For
osteoporoticmodel,SAMP8micereceivedbilateralsalpingo-
oophorectomy at 4 months old and subsequently fed with
DSW for 15 days. The effects of DSW on bone regeneration
were then analyzed by bone mineral density, micro-CT,
bone structure with HE stain, and the activities of isolated
bone marrow stromal cells. Here, we demonstrated that
DSW not only induced bone regeneration but also strongly
recovered bone loss in OVX-SAMP8 mice. In addition, we
have observed that DSW would be effective in prevention of
osteoporosis and might be a complementary and alternative
medicine (CAM).
2. Materials and Methods
2.1. Characterization of Deep Sea Water (DSW). DSW was
obtained from the Pacific Ocean at a depth of 662m
[14, 15]. The obtained DSW was subjected to filtration to
remove microorganism and virus and then concentrated.
The elements contained in concentrated DSW were mea-
sured by inductively coupled plasma mass spectroscopy.
As shown in Supplemental Table 1, the concentrated DSW
contained high amounts of several essential minerals such
as magnesium (Mg), potassium (K), sodium (Na), and cal-
cium (Ca) (see Supplementary Material availbale online at
http://dx.doi.org/10.1155/2013/161976). The final hardness of
concentratedDSWwasdeterminedas400,000mg/Lbyusing
calcium and magnesium concentrations.
2.2. Cell Line and Cell Viability. Mouse preosteoblast cell line
(MC3T3-E1, ATCC CRL-2593) was provided by Dr. Alexan-
der T.H Wu (Taipei medical University, Taipei, Taiwan) and
wasculturedin96wellplates(1×10
4 cells/well)inalphamin-
imum essential medium (𝗼-MEM) supplemented with 10%
fetal bovine serum (FBS) or/and different concentration of
DSW (ranged from 500 to 2000 HD). MTT reagent was
added into each well on day 3 of cell growth in culture, and
cell viability was detected by Multiskan PC (Thermo Lab).
For the cell counting assay, MC3T3 (1 × 10
4) were seeded
in 6cm dish containing DSW-derived medium (hardness of
1000mg/L)and incubated at 37
∘Ci n5 %C O 2 atmosphere.
After 72hrs, MC3T3 were collected, and the cell numbers
were countedby trypsin and ethylenediaminetetraaceticacid
treatment.
2.3. Experimental Animals. All the animal experiment pro-
tocol was approved by the Institutional Animal Care and
Use Committee of Taipei medical University. SAMP8 mice
were ovariectomized (OVX) at 4 months of age to induce
osteoporosis and then used in this experiments. Mice were
grouped into the following (six mice per group): control
group (CTRL, receiving PBS) and DSW group (receiving
DSW). Both mice were suggested for daily water uptake
which is based on a 22g mouse consuming 5.2mL water per
day.
2 . 4 .S e r u mA L P ,M g ,a n dC aA n a l y s e s .All mice were sacri-
ficed and the extracted blood specimens were obtained at
4 months. The plasma concentrations for ALP, Mg, and Ca
were then determined by a photometric method according
to the manufacturer’s instructions (Fuji Dri-Chem Clinical
Chemistry Analyzer FDC 3500).
2.5. Bone Mineral Density and Micro-CT Analysis. Dual-
energy X-ray absorptiometry (DEXA) analysis was used for
the measurement of bone mass in the spine, left/right knee,
and left/right femurs. BMD (XR-36; Norland Corp.; host
software revision 2.5.3, scanner software revision 2.0.0) was
performed4monthsafterDSWtreatment.Allmiceweresac-
rificed and their femurs and tibia bones were collected at 4
monthsfordetectingthetrabecularboneandbonevolumeby
micro-CT (Skyscan-1076, Skyscan, Belgium). For trabecular
bone analysis and 3D imaging, construction was operated
at 50KV, 200uA, 0.4
∘ of rotation step, 0.5mm AI filter, and
9𝜇m/pixelofscanresolution.Eachgroupcontains6animals.
2.6. Histological Analysis. For histological determination,
bonesamplewasfixedin10%formalinanddecalcifiedin14%
EDTA for 3 days. Bone sections (10𝜇m) were subjected to
p a r a ffi n - e m b e d d i n ga n dt h e ns t a i n e dw i t hh e m a t o x y l i na n d
eosin (H&E) staining to detect the trabecular bone in the
bone tissue.
2.7. Isolation of Bone Marrow Cells. Bone marrow stromal
cells (BMSCs) were harvested from femurs and tibias ofEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Optimization of hardness of DSW by cellviability of preosteoblast. Comparative proliferation profiles of preosteoblast (MC3T3) in
DSW-enriched medium were analyzed by MTT assay (optical densities, mean 6 SD for 3 separate replicates). The MC3T3 cells treated with
DSW of hardness (HD) 1000 showed the highest cell viability; 𝑡-test,
∗𝑃 < 0.05.
D S W - t r e a t e dm i c ea n dv e h i c l e - t r e a t e dm i c e( C T R L )a ft e r
4 months treatment. BMSCs were washed out in the bone
marrow and centrifuged at 1000rpm for 5min. Cells were all
culturedin𝗼-MEMsupplementedwith10%FBSforoneweek
to remove the nonadherent cells and then washed with PBS.
The adherent cells, indicated the BMSCs, were collected for
ethylenediaminetetraacetic acid treatment.
2.8. Cell Proliferation and Colony-Forming Unit of BMSCs In
Vivo. BMSCs were cultured in 𝗼-MEM supplemented with
10%FBSand/orDSWtreatmentfor3days, andthecellnum-
bers were counted for evaluating their proliferation. For col-
ony formation assay, BMSCs were cultured in maintenance
medium after 14 days and then fixed with 4% formaldehyde.
Fixed cells were then stained with 0.5% crystal violet in
methanolfor10min,andformedcolonieswerethencounted.
2.9.RT-PCRAnalysis. TotalRNAfromBMSCswasextracted
using TRIzol regent (Invitrogen Life Technologies). Gene
expression levels were measured by RT-PCR. Primer
sequences were indicated as follows: bone morphogenetic
protein (BMP2): forward primer 5
򸀠-GGTCCTTGCACCAA-
GATGAAC-3
򸀠; reverse primer 5
򸀠-CAACCCTCCACAACC-
ATGTC-3
򸀠,a n dt e m p e r a t u r e6 2
∘C; osteopontin (OPN): for-
ward primer 5
򸀠-ATGAGATTGGCAGTGATT-3
򸀠,r e v e r s e
primer 5
򸀠-GTTGACCTCAGAAGATGA-3
򸀠,a n dt e m p e r a -
ture 48.8
∘C; osteocalcin (OCN): forward primer 5
򸀠-CAG-
CTTGGTGCACACCTAAGC-3
򸀠, reverse primer 5
򸀠-AGGG-
TTAAGCTCACACTGCTCC-3
򸀠,a n dt e m p e r a t u r e5 5
∘C;
runt-related transcriptionfactor 2 (RUNX2): forward primer
5
򸀠-ACTTTCTCCAGGAAGACTGC-3
򸀠; reverse primer 5
򸀠-
GCTGTTGTTGCTGTTGCTGT-3
򸀠,a n dt e m p e r a t u r e5 5
∘C;
glyceraldehyde 3-phosphate dehydrogenase (GAPDH): was
used as an internal control (CTRL) forward primer 5
򸀠-
GCTCTCCAGAACATCATCCCTGCC-3
򸀠; reverse primer
5
򸀠-CGTTGTCATACCAGGAAATGAGCTT-3
򸀠,a n dt e m -
perature, 55
∘C. PCR products were separated by electro-
phoresis on 1% agarose gels (Agarose I; AMRESCO) and
visualized with ethidium bromide staining.
2.10.StatisticalAnalysis. Allresultswererepresentedasmean
± standard deviation (SD). Significant differences between
thetwogroupsweredeterminedbyStudent’s𝑡-test,𝑃 value <
0.05.
3. Results
3.1. Effect of Deep Sea Water (DSW) Hardness on the Cell
Growth of Preosteoblast. To determine the effects of different
hardness of DSW water on the cell viability of preosteoblasts,
MC3T3 cells were cultured in DSW-derived medium for
48hrs and analyzed by MTT assay. As shown in Figure 1(a),
the DSW with hardness of 50 and 2000mg/L did not affect
the cell viability of preosteoblasts, yet DSW with hardness
of 1000mg/L slightly increased the cell viability of MC3T3
cells. Hence, we further evaluated the cell growth effects
of DSW with hardness of 1000mg/L on MC3T3 cells by
usingcell-countingassay.After72hrsofculture,MC3T3cells
showed 2- to 3-fold enhanced cell growth in DSW-derived
medium (hardness of 1000mg/L) compared to the control
medium(Figure 1(b)).Theseresultsindicatedthat1000mg/L
displays the optimal hardness of DSW for the cell growth of
preosteoblasts. Therefore, we utilized DSW with hardness of
1000mg/L in the following experiments.
3.2. Effect of DSW on Serum Alkaline Phosphatase (ALP),
Calcium (Ca), and Magnesium (Mg) Activity in OVX-SAMP8
Mice. Based on the in vitro results, DSW of hardness 1000
was applied to OVX-SAMP8 mice for 4 months. We first
evaluated the in vivo osteogenic effects of DSW by using4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: The effect of DSW treatment on serum ALP, Ca, and Mg activity. The serum ALP, Ca and Mg levels after 4 months DSW treatment
was measured by ELISA assay. Serum ALP levels presented a significant decrease in DSW-treated mice (a). In contract, Ca and Mg showed
no significant different in DSW group compared with control mice ((b) and (c)). Each bar represents the average from six animals; 𝑡-test,
∗𝑃 < 0.05 versus CTRL group.
serum levels of ALP, Ca, and Mg. Serum ALP values reflect
the increased turnover associated with bone destruction of
aging, menopause, and various conditions affecting bone
metabolism. Increased serum ALP levels are associated with
an increased risk of rapid bone loss in peri- and post-
menopausal women [19–21]. Ca and Mg play important roles
inbonehomeostasisandmetabolism.Decreasedserumlevels
of Ca and Mg have been shown to contribute to the risk
of osteoporosis [22–24]. After 4 months DSW treatment,
significantly lower ALP activity was evident in the DSW
group as compared to control group (Figure 2(a)), which
meansthatDSWcouldrecoverthebonelossinOVX-SAMP8
mice. Meanwhile, no significant difference was found in Ca
and Mg levels between the DSW and control group (Figures
2(b) and 2(c)).
3.3. Quantitative Analysis of BMD in DSW-Treated Mice.
D S Ww a su s e df o rp r e v e n t i o no fO V X - S A M P 8o s t e o p o r o t i c
mice, and bone density scores of spine, knee (right/left),
and femurs (right/left) were determined by dual-energy
X-ray absorptiometry (general scheme, Figure 3(a)). As
demonstrated in Figure 3, 4 months after treatment, DSW of
hardness 1000 significantly improved BMD of OVX-SAMP8
mice, compared with vehicle-treated OVX-SAMP8 mice,
indicating that DSW induced bone regeneration and recov-
ered bone mass loss in these osteoporotic mice (Figure 3(b)).
3.4. Photomicrographs for Bone Recovery in OVX-SAMP8
Mice by DSW. The improvement in BMD scores in DSW-
treated animals was further supported by bone morpholog-
ical analysis. Both micro-CT 2D and 3D imaging demon-
strated higher trabecular area and volume in DSW-treated
OVX-SAMP8 animals (left and middle two columns, resp.,
Figure 4(a)). Meanwhile, histological sections of bone tissues
from DSW-treated mice also showed more trabecular bone
areas in the bone marrow (right two columns, Figure 4(a)).
A ft e rt h er e l a t i v et r a b e c u l a rb o n ev o l u m er a t i ot ot h et o t a l
bone volume (BV/TV) was measured, it was clear that a
higher percent bone volume ratio (upper panel, Figure 4(b))
and trabecular bone number (lower panel, Figure 4(b))w e r e
also found in DSW-treated OVX-SAMP8 mice.Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Quantitative analysis of BMD in DSW-treated and control mice. Bone density scores (BMD) of spine, knee (right/left), and femurs
(right/left) were measured by Dual-energy X-ray absorptiometry after 4 months treatment (a). DSW-induced bone formation and decreased
bone loss were observed in the DSW-treated OVX-SAMP8 mice (b). Values (means + SD) indicate relative BMD levels normalized to month
0 BMD (before operation = 100%; dashed line), respectively;
∗𝑃 < 0.05 determined by 𝑡-tests; 𝑛=6of each group.6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Effects of DSW on bone structure of OVX-SAMP8 mice. Comparative analyses of bone structure between control and DSW-
treated OVX-SAMP8 mice. Micro-CT imaging observed that bone structure (trabecular/cortical bone, 2D), trabecular bone volume (3D),
andtrabecularbonemasswereincreasedintheDSW-treatedOVX-SAMP8miceafter4monthstreatment.H&Estainingrepresentedahigher
ratio of bone mass in DSW-treated mice (a). The volume of trabecular bone (bone volume/total bone volume (BV/TV)), and the numbers of
trabecular bone (Tb.N) were calculated (right panel), and bars represented the average from six animals (b); 𝑡-test,
∗𝑃 < 0.05 versus CTRL
group.
3.5. The Proliferation and Colony-Forming Ability of Bone
Marrow Stem Cell (BMSC) Derived from DSW-Treated Mice.
To validate these observations and determine the effect of
DSW on bone microenvironment in OVX-SAMP8 mice,
BMSCs in DSW-treated mice were isolated and examined
for cell proliferation and colony-forming ability (general
scheme,Figure 5(a)).TheBMSCsfromDSW-treatedSAMP8
mice demonstrated significantly higher proliferative activity
and higher numbers of colonies as compared to those from
vehicle-treatedmiceafter7daysincubation(Figures5(b)and
5(c)). This finding suggested that the BMSCs from DSW-
treated SAMP8 mice had statistically significant proliferative
and colony-forming abilities.
3.6. Effects of DSW on Osteogenic Differentiation of BMSCs
In Vivo. Following the characterization scheme in Figure 5,
osteogenicdifferentiationmarkers,includingBMP2(regulate
the transcription factor Runx2 expression), RUNX2 (an early
stagemarkerforosteogenesis),OPN(anintermediatemarker
for osteogenesis), and OCN (a late stage marker for osteo-
genesis) mRNA transcripts of BMSCs from DSW-treated
OVX-SAMP8, were examined and compared. The mRNA
level of RUNX2, BMP2, OPN, and OCN was significantly
upregulated in DSW-treated mice when compare to control
mice (Figure 6(a)). Moreover, the Alizarin Red S staining
showed an increased level of matrix mineralization in the
BMSCs isolated from the DSW-treated group, as compared
to the control group (Figure 6(b)).
3.7. Survival of Osteoporotic Mice Treated with DSW. Inaddi-
tion to significantly improving bone trabecular architecture
and BMD, the DSW could extend the life span of OVX-
SAMP8 mice, which was markedly longer than that of the
untreated OVX-SAMP8 (Figure 7). Most untreated OVX-
SAMP8micediedaround10months;however,approximately
57% of DSW-treated groups lived up to 16.6 months, a life
expectancy similar to the previously reported life expectancy
for SAMR1 24 months [16].
4. Discussion
Previously, we have demonstrated the osteogenic regener-
ation mechanism by stem cells and platelet-rich plasma
in OVX-SAMP8 mice [16]. In this study, we extended toEvidence-Based Complementary and Alternative Medicine 7
CTRL DSW
0
20
40
60
80
012345678
0
1
2
3
4
5
CTRL
DSW
∗
CTRL DSW
BMCs harvest
Comparative characterization of BMCs
Osteoporotic mice
4 months treatment
MTT analysis
Days
Colony formation
(a)
(b) (c)
R
a
t
i
o
C
o
l
o
n
y
 
n
u
m
b
e
r
s
Figure 5: Ex vivo proliferation and colony-forming ability of isolated BMSCs. Comparative proliferation profiles of BMSCs from DSW and
vehicle-treatedmiceweredemonstratedbyMTTassay((a)and(b)).BMSCswereculturedfor14days,andtheircolonyformingabilitieswere
assayed. Data was expressed quantitatively in the upper panel (c). Representative results of 3 experiments are demonstrated; 𝑡-test,
∗𝑃 < 0.05
versus CTRL group.
examine the feasibility of using deep sea water (DSW) as
a molecular cocktail to modulate the osteogenesis in osteo-
porotic mouse model. DSW contained major trace elements
such as magnesium (Mg) and calcium (Ca), that have been
reported to regulate bone metabolism. Mg and Ca were also
found to induce murine osteoblast differentiation in MC3T3
cells. When MC3T3 cells were cultured in Mg- and Ca-free
medium, their osteoblast differentiation marker osteocalcin
(OCN) was reduced [25]. Epidemiologic studies showed a
good correlation between Mg/Ca and bone density, in which
low Mg and Ca intake might decrease bone mass [26, 27],
bone turnover, and also cause high risk of fracture and
osteoporosis. Moreover, the hardness (HD) of DSW which
resulted from the composition of Mg and Ca also reported
to modulate osteogenesis [28, 29]. In this study, our result
showedthatDSWofhardness1000(1000HD)appearedtobe
the optimal condition for osteoblast proliferation (Figure 1)
and was applied for later experiments.
Serum alkaline phosphatase (ALP) is a group of enzymes
found primarily in bone tissue. The primary importance of
measuringALPistocheckthepossibilityofbonediseasesuch
as fractures and bone loss [30, 31]. The decreased serum ALP
activity and bone mass recovery were found in early
postmenopausal woman with osteoporosis after hormone
replacement therapy [32]. From the biochemical analysis,
OVX-SAMP8 mice exhibited decreased ALP activity after
4 months DSW treatment (Figure 2). The decreased ALP
activities were evidenced by bone mineral density (BMD)
which indicated that bone quality in OVX-SAMP8 mice was
enhanced by DSW (Figure 3). Interestingly, there was no
significant difference in Ca and Mg levels after DSW treat-
ment compared to control group. In the present study, OVX-
SAMP8 mice exhibited increased BMD and decreased bone
loss after 4 months treatment with DSW. The histological
and micro-CT 2D and 3D imaging data also demonstrated
thatBV/TVratio,trabecularbonenumbers,andvolumewere
strongly enhanced in DSW-treated OVX-SAMP8 animals
(Figure 4) .B M Dh a sb e e ns h o w nt ob ea ni m p o r t a n tf a c t o r
to determine the strength of cancellous bone and trabecular
bone [33, 34]. In addition to BMD, trabecular structural
parameters,suchasfractaldimensionortissuevolume,could
enhance the prediction of bone mechanical quality [35, 36].
These analyses indicated that DSW treatment reduced the
bone loss and induced the bone recovery.8 Evidence-Based Complementary and Alternative Medicine
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Figure6:Comparativeexpressionprofileofosteogenic differentiation markersofBMSCsinosteoporoticmice. EffectofDSWonosteogenic
mRNA expression in specific genes including bone morphogenetic protein 2 (BMP2), runt-related transcription factor 2 (RUNX2),
Osteopontin (OPN) and Osteocalcin (OCN) of BMSCs was quantitatively measured ((a), right/left panel). The maturation of osteogenic
differentiation was then examined by Alizarin Red S staining (b), and more calcium nodules were formed in DSW group. Representative
results of 3 experiments are demonstrated;
∗𝑃 < 0.05 versus CTRL group.
Interestingly, we initially used in vitro osteoblast cell
culture to determine the effects of DSW on cell prolifer-
ation and colony formation; however, no effects were found
(data not shown). Metabolism would be an important fac-
tor to be considered. Therefore, an alternative approach
was designed and shown in general scheme of Figure 5(a).
After administration of DSW, BMSCs in DSW-treated mice
were then isolated and examined for cell proliferation
and colony-forming ability. BMSCs obtained from DSW-
treated mice showed markedly induction in osteogenesis-
related molecules including BMP2, RUNX2, OPN, and OCN
(Figure 6). BMP2 has been shown to regulate osterix via
RUNX2 [37], an essential transcription factor for osteoblast
differentiation[38].Duringosteogenesis,OPNisaninterme-
diate marker, while OCN is a late stage marker of osteoblasts
[39]. DSW was found to strongly modulate the molecular
determinants in bone microenvironment for osteogenesis.
Meanwhile, the higher cell growth and colony formation
w e r ea l s od e t e c t e di nb o n em a r r o wc e l l si s o l a t e df r o mD S W -
t r e a t e dm i c e( Figure 5). Taken together, DSW treatment
enhanced bone formation in OVX-SAMP8 mice through
metabolism.Evidence-Based Complementary and Alternative Medicine 9
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Figure7:SurvivalofDSW-treatedOVX-SAMP8mice.TheKaplan-
Meyer survival plots of mice from DSW (-∙-) and vehicle groups
(-I-) were shown.
Our data demonstrated that therapy with DSW appeared
toprolongthelifespanofOVX-SAMP8mice(Figure 7).Pre-
viously, we have shown that cell therapy with growth factors
(PRP/NIH3T3-G) prolongedthelifespanoftheosteoporotic
mice through the bone mass recovery [16]. Epidemiologic
studies indicated that the high mortality of hip fractures
patients was 3-fold higher than those of general population.
I nc o n t r a s t ,t h ei n c r e a s e db o n em a s sc a na l s or e d u c et h e
risk of bone fracture and subsequently increase the life
expectancyinosteoporoticpatients[40–42].DSWtreatment
strongly indicated that not only bone mass was recovered
but also osteogenesis was induced in osteoporotic mice and
thenpotentiallyimproving(regenerating)theirstructureand
function in degenerative lesions, aging tissue, and organs.
F u r t h e r m o r e ,D S Wt r e a t m e n tc o u l db ea p p l i e df o rr e j u v e n a -
tion therapy and bone regeneration for prolongation of life.
5. Conclusion
In this study, the potential effects of DSW on bone regener-
ation in osteoporosis recovery were investigated; we found
that DSW promoted osteoblast viability and increased BMD
scores, trabecular bone numbers, and ameliorated symptoms
of osteoporosis. These findings suggest that DSW could be
a useful treatment for preventing osteoporosis in the near
future.
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